3 Healthcare Stocks Buzz in Trading Spotlight Following Earnings

Eli Lilly and Company (NYSE:LLY) reported its results for the first quarter. Net income for Eli Lilly and Company fell to $1.01 billion (91 cents per share) vs. $1.06 billion (95 cents per share) a year earlier. This is a decline of 4.2% from the year-earlier quarter. Revenue fell 4.1% to $5.6 billion from the year-earlier quarter. Eli Lilly and Company reported adjusted net income of 92 cents per share. By that measure, the company beat the mean estimate of 78 cents per share. It beat the average revenue estimate of $5.35 billion.

Wellpoint Inc. (NYSE:WLP) reported its results for the first quarter. Net income for the medical-HMO fell to $856.5 million ($2.53 per share) vs. $926.6 million ($2.44 per share) a year earlier. This is a decline of 7.6% from the year-earlier quarter. Revenue rose 3.4% to $15.15 billion from the year-earlier quarter. Wellpoint Inc. reported adjusted net income of $2.34 per share. By that measure, the company beat the mean estimate of $2.28 per share. Analysts were expecting revenue of $15.26 billion.

Thermo Fisher Scientific Inc. (NYSE:TMO) reported net income above Wall Street’s expectations for the first quarter. Net income for Thermo Fisher Scientific Inc. rose to $277.3 million (75 cents per share) vs. $252.2 million (64 cents per share) in the same quarter a year earlier. This marks a rise of 10% from the year-earlier quarter. Revenue rose 13.9% to $3.1 billion from the year-earlier quarter. Thermo Fisher Scientific Inc. reported adjusted net income of $1.17 per share. By that measure, the company beat the mean estimate of $1.11 per share. It beat the average revenue estimate of $2.98 billion.